Key points are not available for this paper at this time.
Genomic sequencing is revealing complex molecular profiles that differ by patient. Multidisciplinary molecular tumor boards may help optimize management. Barriers to personalized therapy include access to appropriately targeted drugs.
Schwaederlé et al. (Mon,) studied this question.